BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 30539831)

  • 1. Identification of differentiated functional modules in papillary thyroid carcinoma by analyzing differential networks.
    Yang C; Wang Y
    J Cancer Res Ther; 2018 Dec; 14(Supplement):S969-S974. PubMed ID: 30539831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of key genes of papillary thyroid carcinoma by integrated bioinformatics analysis.
    Xue G; Lin X; Wu JF; Pei D; Wang DM; Zhang J; Zhang WJ
    Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32766727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BCL2 and hsa-miR-181a-5p are potential biomarkers associated with papillary thyroid cancer based on bioinformatics analysis.
    Zhang C; Bo C; Guo L; Yu P; Miao S; Gu X
    World J Surg Oncol; 2019 Dec; 17(1):221. PubMed ID: 31842912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of potential biomarkers for papillary thyroid carcinoma by comprehensive bioinformatics analysis.
    Liao M; Wang Z; Yao J; Xing H; Hao Y; Qiu B
    Mol Cell Biochem; 2023 Sep; 478(9):2111-2123. PubMed ID: 36635603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identifying gene modules of thyroid cancer associated with pathological stage by weighted gene co-expression network analysis.
    Tang X; Huang X; Wang D; Yan R; Lu F; Cheng C; Li Y; Xu J
    Gene; 2019 Jul; 704():142-148. PubMed ID: 30965127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome-wide scanning for CHD1L gene in papillary thyroid carcinoma complicated with type 2 diabetes mellitus.
    Kang YY; Li JJ; Sun JX; Wei JX; Ding C; Shi CL; Wu G; Li K; Ma YF; Sun Y; Qiao H
    Clin Transl Oncol; 2021 Dec; 23(12):2536-2547. PubMed ID: 34245428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of biomarkers associated with cervical lymph node metastasis in papillary thyroid carcinoma: Evidence from an integrated bioinformatic analysis.
    Zhang Z; Zhao S; Wang K; Shang M; Chen Z; Yang H; Chen Y; Chen B
    Clin Hemorheol Microcirc; 2021; 78(2):117-126. PubMed ID: 33554894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Network medicine approaches for identification of novel prognostic systems biomarkers and drug candidates for papillary thyroid carcinoma.
    Kori M; Temiz K; Gov E
    J Cell Mol Med; 2023 Dec; 27(24):4171-4180. PubMed ID: 37859510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of differential pathways in papillary thyroid carcinoma utilizing pathway co-expression analysis.
    Qiu WH; Chen GY; Cui L; Zhang TM; Wei F; Yang Y
    J BUON; 2016; 21(6):1501-1509. PubMed ID: 28039715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of gene co-expression modules and hub genes associated with lymph node metastasis of papillary thyroid cancer.
    Zhai T; Muhanhali D; Jia X; Wu Z; Cai Z; Ling Y
    Endocrine; 2019 Dec; 66(3):573-584. PubMed ID: 31332712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of differentially expressed genes and long non-coding RNAs in papillary thyroid carcinoma diagnosis, progression, and prognosis.
    Cai WY; Chen X; Chen LP; Li Q; Du XJ; Zhou YY
    J Cell Biochem; 2018 Nov; 119(10):8249-8259. PubMed ID: 29968931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Key candidate genes associated with BRAF
    Yu X; Zhong P; Han Y; Huang Q; Wang J; Jia C; Lv Z
    J Cell Physiol; 2019 Dec; 234(12):23369-23378. PubMed ID: 31161615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of key genes and miRNAs markers of papillary thyroid cancer.
    Qiu J; Zhang W; Zang C; Liu X; Liu F; Ge R; Sun Y; Xia Q
    Biol Res; 2018 Nov; 51(1):45. PubMed ID: 30414611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations of regulatory factors and DNA methylation pattern in thyroid cancer.
    Iancu IV; Botezatu A; Plesa A; Huica I; Fudulu A; Albulescu A; Bostan M; Mihaila M; Grancea C; Manda DA; Dobrescu R; Vladoiu SV; Anton G; Badiu CV
    Cancer Biomark; 2020; 28(2):255-268. PubMed ID: 32390600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrative Analysis of Potential Biomarkers Involved in the Progression of Papillary Thyroid Cancer.
    Bansal R; Saxena U
    Appl Biochem Biotechnol; 2023 May; 195(5):2917-2932. PubMed ID: 36445679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. lncRNA DUXAP8 inhibits papillary thyroid carcinoma cell apoptosis via sponging the miR‑20b‑5p/SOS1 axis.
    Pang R; Yang S
    Oncol Rep; 2021 May; 45(5):. PubMed ID: 33760128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BGL3 inhibits papillary thyroid carcinoma progression via regulating PTEN stability.
    Zhao M; Yang F; Sang C; Yan C; Wang Z
    J Endocrinol Invest; 2021 Oct; 44(10):2165-2174. PubMed ID: 33543443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential expression of a set of microRNA genes reveals the potential mechanism of papillary thyroid carcinoma.
    Feng Z; Song Y; Qian J; Chen T; Yang C; Jia L; Liu C; Liu P; Lv J; Deng Z
    Ann Endocrinol (Paris); 2019 Apr; 80(2):77-83. PubMed ID: 30685058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and analysis of genes associated with papillary thyroid carcinoma by bioinformatics methods.
    Zhang S; Wang Q; Han Q; Han H; Lu P
    Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30872410
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Wen J; Lin B; Lin L; Chen Y; Wang O
    Aging (Albany NY); 2020 Aug; 12(16):16437-16456. PubMed ID: 32857728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.